Prevalence of drug resistance mutations in Spain among both naive and pretreated patients

Antiviral Therapy

Volumn 4, Issue SUPPL. 3, 1999, Pages 57-63

  Soriano, Vincent ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; DIDANOSINE; LAMIVUDINE; NUCLEOSIDE ANALOG; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; VIRUS RNA; ZALCITABINE; ZIDOVUDINE;

ADULT; CODON; CONFERENCE PAPER; DEMOGRAPHY; DRUG SCREENING; FEMALE; GENE INSERTION; GENOTYPE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PLASMA; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVERTANT; SPAIN; VIRUS MUTATION; VIRUS RESISTANCE;

ADULT; ANTI-HIV AGENTS; CROSS-SECTIONAL STUDIES; DRUG RESISTANCE, VIRAL; DRUG THERAPY, COMBINATION; FEMALE; HIV INFECTIONS; HIV PROTEASE; HIV-1; HIV-1 REVERSE TRANSCRIPTASE; HUMANS; MALE; MIDDLE AGED; MUTATION; PREVALENCE; REVERSE TRANSCRIPTASE INHIBITORS; SPAIN;

EID: 0032715140     PISSN: 13596535     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (4)

1. Gómez-Cano M, Rubio A, Puig T et al. Prevalence of genotypic resistance to nucleoside analogues in antiretroviral-naive and antiretroviral-experienced HIV-infected patients in Spain. AIDS 1998; 12:1015-1020.
2. Mayers D, Merigan T, Gilbert P for the ACTG 244 Study Team. T215Y/F mutation associated with ZDV resistance leads to poor response to ZDV+ddI or ZDV+ddI+NVP. 6th Conference on Retroviruses & Opportunistic Infections, Chicago, Illinois, January 31-February 4, 1999, Abstract 129.
3. Miller V, Gute P, Carlebach A et al. Baseline resistance and virological response to mega-HAART salvage therapies. 6th Conference on Retroviruses & Opportunistic Infections, Chicago, Illinois, January 31-February 4, 1999, Abstract 130.
4. Demeter L, De Gruttola V, Eshleman S et al. Baseline protease and reverse transcriptase genotype as a predictor of response to ZDV+3TC+IDV. 6th Conference on Retroviruses & Opportunistic Infections, Chicago, Illinois, January 31-February 4, 1999, Abstract 131.